Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.25 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.94.
Market Cap
9.25T
Revenue
4.67T
Profits
189.01B
PE Ratio
48.94
Profit Margin
4.05%
Dividend Yield
0.38%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 1.04% | 2,480,051 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 649.40B | -0.19% | 4,487,725 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 467.37B | 0.20% | 3,438,150 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 368.84B | 1.79% | 7,996,434 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 338.90B | 0.18% | 5,712,251 | 450.53B |
| 6 | NVS | Novartis AG | 268.82B | 0.43% | 1,554,268 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 260.49B | 1.22% | 2,937,798 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 243.57B | 1.12% | 2,303,877 | 46.34B |
| 9 | AMGN | Amgen Inc. | 212.55B | 1.95% | 2,889,257 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 186.69B | 0.30% | 5,569,448 | 30.46B |
| 11 | ABT | Abbott Laboratories | 178.19B | 0.36% | 5,018,288 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 176.42B | -7.96% | 49,339,315 | 50.34B |
| 13 | PFE | Pfizer Inc. | 158.11B | 0.29% | 28,776,627 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.73B | 1.90% | 5,164,083 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.89B | 2.12% | 2,972,892 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 129.45B | 0.47% | 906,682 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.91B | -0.70% | 6,839,126 | 49.19B |
| 18 | MDT | Medtronic plc | 117.36B | -0.41% | 7,311,927 | 37.54B |
| 19 | CVS | CVS Health Corporation | 112.04B | -1.40% | 10,137,932 | 412.65B |
| 20 | SYK | Stryker Corporation | 105.17B | -0.34% | 2,759,206 | 25.84B |
| 21 | MCK | McKesson Corporation | 103.35B | 1.35% | 940,314 | 410.98B |
| 22 | SNY | Sanofi | 102.49B | 0.05% | 2,484,466 | 55.89B |
| 23 | GSK | GSK plc | 102.39B | 1.71% | 2,872,198 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.22B | -0.41% | 1,418,517 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 88.77B | -0.40% | 933,962 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.70B | 1.70% | 704,527 | 15.53B |
| 27 | CI | The Cigna Group | 72.53B | -0.29% | 1,394,988 | 282.38B |
| 28 | MRNA | Moderna, Inc. | 69.04B | 12.27% | 21,018,289 | 2.23B |
| 29 | BSX | Boston Scientific Corporation | 63.36B | 0.88% | 24,998,920 | 21.00B |
| 30 | ARGX | argenx SE | 62.26B | -0.21% | 231,649 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.71B | -0.11% | 1,756,150 | 28.42B |
| 32 | COR | Cencora, Inc. | 60.39B | 2.50% | 1,049,948 | 332.77B |
| 33 | NTRA | Natera, Inc. | 53.43B | 0.34% | 1,981,768 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 52.27B | 0.16% | 1,189,139 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 50.92B | 0.09% | 3,347,115 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.22B | -0.13% | 1,461,542 | 22.48B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 46.68B | 2.77% | 5,941,719 | 17.32B |
| 38 | A | Agilent Technologies, Inc. | 45.66B | 3.50% | 2,710,410 | 7.37B |
| 39 | HUM | Humana Inc. | 45.46B | -1.98% | 925,969 | 145.68B |
| 40 | IQV | IQVIA Holdings Inc. | 44.42B | 1.30% | 1,928,128 | 16.98B |
| 41 | VEEV | Veeva Systems Inc. | 42.31B | 0.42% | 1,199,187 | 3.46B |
| 42 | MDLN | Medline Inc. | 42.02B | 1.01% | 10,490,643 | 29.94B |
| 43 | WAT | Waters Corporation | 41.65B | 0.54% | 782,410 | 4.64B |
| 44 | ONC | BeOne Medicines AG | 41.58B | 4.23% | 488,977 | 6.13B |
| 45 | RVMD | Revolution Medicines, Inc. | 41.32B | 0.95% | 1,888,943 | - |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.60B | 0.71% | 513,207 | 4.55B |
| 47 | HLN | Haleon plc | 40.38B | 0.86% | 40,721,397 | 14.80B |
| 48 | ILMN | Illumina, Inc. | 36.06B | -0.33% | 3,188,896 | 4.49B |
| 49 | DXCM | DexCom, Inc. | 33.65B | -0.20% | 3,515,967 | 4.97B |
| 50 | RPRX | Royalty Pharma plc | 33.60B | 0.05% | 3,231,940 | 2.54B |
| 51 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.69B | 1.99% | 1,152,874 | 4.80B |
| 52 | BIIB | Biogen Inc. | 32.37B | 1.66% | 928,562 | 10.03B |
| 53 | CNC | Centene Corporation | 32.10B | -0.18% | 4,423,083 | 180.30B |
| 54 | RMD | ResMed Inc. | 31.99B | -0.61% | 1,072,145 | 5.65B |
| 55 | ALC | Alcon Inc. | 31.50B | -0.26% | 1,315,195 | 10.86B |
| 56 | ZTS | Zoetis Inc. | 29.48B | -0.10% | 3,946,568 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.27B | 1.06% | 3,496,469 | 21.27B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.66B | 2.74% | 168,939 | 4.13B |
| 59 | ROIV | Roivant Sciences Ltd. | 28.16B | -1.96% | 5,620,751 | 7.53M |
| 60 | DGX | Quest Diagnostics Incorporated | 27.03B | -0.64% | 907,606 | 11.56B |
| 61 | INSM | Insmed Incorporated | 26.42B | 0.83% | 1,812,278 | 1.14B |
| 62 | LH | Labcorp Holdings Inc. | 26.03B | 0.09% | 487,756 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.46B | -0.15% | 506,797 | 3.33B |
| 64 | INCY | Incyte Corporation | 25.27B | -0.53% | 1,270,532 | 5.82B |
| 65 | BNTX | BioNTech SE | 24.62B | 2.02% | 801,206 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.35B | 0.89% | 634,305 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.33B | -3.07% | 2,623,996 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.15B | -0.31% | 1,185,699 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.01B | -0.39% | 670,824 | 21.81B |
| 70 | GMAB | Genmab A/S | 20.72B | -0.14% | 1,577,462 | 4.13B |
| 71 | STE | STERIS plc | 20.18B | 0.94% | 984,638 | 6.04B |
| 72 | VTRS | Viatris Inc. | 19.64B | 0.88% | 6,935,045 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.99B | -1.09% | 1,600,262 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.42B | 1.94% | 188,233 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.02B | 0.10% | 2,062,048 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.67B | 0.30% | 499,163 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 15.60B | 0.37% | 822,985 | 1.20B |
| 78 | SOLV | Solventum Corporation | 15.12B | - | 660,322 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.63B | -1.55% | 1,385,321 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.18B | -1.95% | 2,102,597 | 2.44B |
| 81 | TEM | Tempus AI, Inc. | 14.08B | 0.24% | 5,641,933 | 1.43B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.48B | -5.32% | 5,780,848 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.32B | 0.34% | 952,933 | 4.00B |
| 84 | ICLR | ICON Public Limited Company | 13.08B | 3.31% | 1,031,665 | 8.29B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 13.02B | -0.05% | 3,167,440 | 713.07M |
| 86 | HALO | Halozyme Therapeutics, Inc. | 12.65B | -0.89% | 2,876,988 | 1.66B |
| 87 | PEN | Penumbra, Inc. | 12.56B | 0.37% | 293,927 | 1.50B |
| 88 | BMRN | BioMarin Pharmaceutical Inc. | 12.40B | 0.19% | 1,877,055 | 3.41B |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.30B | 3.15% | 1,346,986 | 830.81M |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.06B | -1.80% | 186,149 | 1.28B |
| 91 | EHC | Encompass Health Corporation | 11.99B | -0.16% | 801,517 | 6.21B |
| 92 | BAX | Baxter International Inc. | 11.85B | 0.57% | 11,747,738 | 11.47B |
| 93 | FMS | Fresenius Medical Care AG | 11.81B | 0.09% | 707,321 | 22.19B |
| 94 | BTSG | BrightSpring Health Services, Inc. | 11.64B | -1.62% | 2,658,809 | 14.37B |
| 95 | SNN | Smith & Nephew plc | 11.63B | 0.47% | 1,166,447 | 6.30B |
| 96 | DVA | DaVita Inc. | 11.63B | -0.83% | 565,042 | 14.01B |
| 97 | TECH | Bio-Techne Corporation | 11.36B | 0.14% | 4,666,996 | 1.22B |
| 98 | ELAN | Elanco Animal Health Incorporated | 11.21B | 0.04% | 4,608,548 | 5.02B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 10.76B | -1.10% | 543,472 | 776.57M |
| 100 | RDY | Dr. Reddy's Laboratories Limited | 10.45B | 1.72% | 2,386,184 | 3.50B |
| 101 | ALGN | Align Technology, Inc. | 10.43B | -0.49% | 975,815 | 4.14B |
| 102 | TWST | Twist Bioscience Corporation | 10.40B | -0.69% | 2,239,631 | 431.80M |
| 103 | TXG | 10x Genomics, Inc. | 10.31B | 3.26% | 2,447,270 | 616.91M |
| 104 | MOH | Molina Healthcare, Inc. | 10.30B | -1.49% | 640,883 | 42.47B |
| 105 | UHS | Universal Health Services, Inc. | 10.30B | -1.10% | 924,624 | 18.11B |
| 106 | COO | The Cooper Companies, Inc. | 10.29B | -2.12% | 4,186,124 | 4.24B |
| 107 | AVTR | Avantor, Inc. | 10.21B | -2.71% | 9,194,159 | 6.56B |
| 108 | RGEN | Repligen Corporation | 10.20B | 2.16% | 857,649 | 785.10M |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 10.09B | 0.24% | 311,466 | 2.59B |
| 110 | ENSG | The Ensign Group, Inc. | 10.08B | 0.32% | 335,085 | 5.49B |
| 111 | GMED | Globus Medical, Inc. | 9.97B | 0.28% | 1,248,349 | 3.14B |
| 112 | KRYS | Krystal Biotech, Inc. | 9.88B | -0.84% | 210,266 | 440.48M |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.78B | -0.07% | 636,938 | 105.00M |
| 114 | PODD | Insulet Corporation | 9.75B | -0.05% | 1,335,832 | 3.05B |
| 115 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.72B | 3.47% | 2,347,934 | 669.50M |
| 116 | OSCR | Oscar Health, Inc. | 9.65B | -2.61% | 8,434,732 | 15.32B |
| 117 | GKOS | Glaukos Corporation | 9.52B | -1.39% | 806,469 | 612.84M |
| 118 | HSIC | Henry Schein, Inc. | 9.50B | 0.42% | 1,347,557 | 13.60B |
| 119 | CYTK | Cytokinetics, Incorporated | 9.39B | -1.77% | 1,603,485 | 67.67M |
| 120 | BRKR | Bruker Corporation | 9.38B | 0.39% | 1,597,474 | 3.50B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.38B | 1.38% | 822,199 | 281.99M |
| 122 | QGEN | Qiagen N.V. | 9.26B | 3.35% | 1,855,337 | 2.10B |
| 123 | ABVX | ABIVAX Société Anonyme | 9.06B | -1.51% | 974,844 | 5.80M |
| 124 | IBRX | ImmunityBio, Inc. | 8.96B | -0.35% | 12,238,177 | 165.79M |
| 125 | PCVX | Vaxcyte, Inc. | 8.77B | 1.36% | 1,124,395 | - |
| 126 | CAI | Caris Life Sciences, Inc. | 8.66B | 2.23% | 6,146,710 | 989.61M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.34B | -0.03% | 543,834 | 7.46M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 8.11B | 1.97% | 1,448,750 | - |
| 129 | TGTX | TG Therapeutics, Inc. | 8.11B | 0.51% | 2,142,757 | 799.54M |
| 130 | ATR | AptarGroup, Inc. | 7.85B | -0.84% | 424,448 | 3.93B |
| 131 | HQY | HealthEquity, Inc. | 7.82B | -0.65% | 655,650 | 1.36B |
| 132 | IMVT | Immunovant, Inc. | 7.68B | 0.62% | 1,031,384 | - |
| 133 | HNGE | Hinge Health, Inc. | 7.62B | -0.47% | 1,125,738 | 720.06M |
| 134 | IONS | Ionis Pharmaceuticals, Inc. | 7.46B | 1.04% | 4,521,358 | 874.09M |
| 135 | ALKS | Alkermes plc | 7.41B | 1.82% | 3,732,233 | 1.67B |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.02B | 7.75% | 5,908,094 | 3.12B |
| 137 | BLTE | Belite Bio, Inc | 6.98B | 1.43% | 119,782 | - |
| 138 | CGON | CG Oncology, Inc. | 6.94B | 4.86% | 1,115,057 | 6.23M |
| 139 | HIMS | Hims & Hers Health, Inc. | 6.85B | 4.86% | 8,446,731 | 2.58B |
| 140 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.80B | 1.15% | 613,603 | 239.92M |
| 141 | PACS | PACS Group, Inc. | 6.66B | -0.14% | 726,939 | 5.55B |
| 142 | GRFS | Grifols, S.A. | 6.56B | 0.68% | 356,734 | 8.48B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.55B | -0.27% | 786,680 | 1.56B |
| 144 | CHE | Chemed Corporation | 6.50B | -0.88% | 159,285 | 2.60B |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.18B | -1.66% | 1,185,413 | - |
| 146 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.10B | 1.15% | 482,846 | 840.85M |
| 147 | BLCO | Bausch + Lomb Corporation | 6.00B | -0.30% | 482,801 | 5.32B |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 5.97B | 0.19% | 685,078 | 618.07M |
| 149 | LQDA | Liquidia Corporation | 5.95B | -0.67% | 1,010,233 | 450.91M |
| 150 | MMED | MiniMed Group, Inc. | 5.94B | -3.07% | 2,332,311 | 3.22B |
| 151 | TVTX | Travere Therapeutics, Inc. | 5.93B | 0.16% | 1,583,778 | 591.33M |
| 152 | STVN | Stevanato Group S.p.A. | 5.87B | -0.88% | 475,481 | 1.40B |
| 153 | SRRK | Scholar Rock Holding Corporation | 5.87B | 3.24% | 2,904,214 | - |
| 154 | LGND | Ligand Pharmaceuticals Incorporated | 5.78B | 2.32% | 237,475 | 290.54M |
| 155 | RDNT | RadNet, Inc. | 5.72B | -4.38% | 796,172 | 2.27B |
| 156 | CRSP | CRISPR Therapeutics AG | 5.64B | 3.13% | 1,814,156 | 13.39M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.55B | 1.59% | 3,415,438 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.45B | -0.17% | 1,086,198 | 1.01B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.40B | -0.35% | 933,209 | 1.90M |
| 160 | SHC | Sotera Health Company | 5.34B | -0.16% | 2,145,775 | 1.22B |
| 161 | TFX | Teleflex Incorporated | 5.29B | 0.22% | 815,185 | 2.25B |
| 162 | DFTX | Definium Therapeutics, Inc. | 5.28B | 1.21% | 2,038,016 | - |
| 163 | ERAS | Erasca, Inc. | 5.26B | 1.83% | 4,151,216 | - |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.10B | 0.14% | 379,902 | 1.58B |
| 165 | HAE | Haemonetics Corporation | 4.95B | 0.30% | 327,026 | 1.35B |
| 166 | WAY | Waystar Holding Corp. | 4.93B | 0.19% | 1,981,953 | 1.21B |
| 167 | BLLN | BillionToOne, Inc. | 4.90B | -1.94% | 412,705 | 397.41M |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.85B | -1.50% | 1,178,390 | - |
| 169 | LFST | LifeStance Health Group, Inc. | 4.84B | 0.80% | 3,312,997 | 1.58B |
| 170 | GRAL | GRAIL, Inc. | 4.82B | 33.68% | 3,528,615 | 165.26M |
| 171 | DOCS | Doximity, Inc. | 4.78B | 2.80% | 2,626,148 | 655.57M |
| 172 | MANE | Veradermics, Incorporated | 4.71B | 5.67% | 584,679 | - |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 4.62B | -0.59% | 13,129,488 | 324.97M |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.56B | -11.50% | 1,705,743 | 148.00K |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | -3.28% | 1,351,979 | 1.14B |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.45B | -2.62% | 1,458,727 | 308.08M |
| 177 | CON | Concentra Group Holdings Parent, Inc. | 4.43B | -1.97% | 743,223 | 2.29B |
| 178 | HTFL | HeartFlow, Inc. | 4.38B | -0.83% | 1,380,864 | 212.07M |
| 179 | LIVN | LivaNova PLC | 4.31B | 0.21% | 579,154 | 1.47B |
| 180 | ITGR | Integer Holdings Corporation | 4.30B | 0.08% | 685,650 | 1.84B |
| 181 | INDV | Indivior Pharmaceuticals, Inc. | 4.19B | 1.86% | 1,298,962 | 1.33B |
| 182 | CELC | Celcuity Inc. | 4.11B | 4.21% | 718,129 | - |
| 183 | ABCL | AbCellera Biologics Inc. | 4.10B | 0.24% | 4,426,944 | 66.17M |
| 184 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.07B | -0.06% | 1,005,645 | -665.00K |
| 185 | TLX | Telix Pharmaceuticals Limited | 4.06B | -10.17% | 865,930 | 890.79M |
| 186 | RLAY | Relay Therapeutics, Inc. | 3.99B | -3.45% | 3,029,903 | 10.35M |
| 187 | ICUI | ICU Medical, Inc. | 3.88B | 1.68% | 223,437 | 2.16B |
| 188 | PLSE | Pulse Biosciences, Inc. | 3.80B | -1.04% | 382,256 | 1.19M |
| 189 | XENE | Xenon Pharmaceuticals Inc. | 3.78B | -1.91% | 4,049,542 | 7.50M |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.77B | 2.67% | 2,555,505 | 53.81M |
| 191 | NVST | Envista Holdings Corporation | 3.76B | 0.34% | 3,537,216 | 2.86B |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 3.75B | 1.17% | 571,096 | 234.13M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.64B | 0.96% | 385,079 | 825.34M |
| 194 | OGN | Organon & Co. | 3.59B | - | 3,116,480 | 6.13B |
| 195 | LEGN | Legend Biotech Corporation | 3.59B | 5.22% | 2,833,024 | 1.27B |
| 196 | OPCH | Option Care Health, Inc. | 3.59B | -1.44% | 3,120,461 | 5.69B |
| 197 | ELVN | Enliven Therapeutics, Inc. | 3.58B | -1.17% | 2,281,267 | - |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.51B | 3.86% | 5,086,725 | - |
| 199 | NHC | National HealthCare Corporation | 3.50B | 0.54% | 103,567 | 1.56B |
| 200 | TARS | Tarsus Pharmaceuticals, Inc. | 3.40B | -0.81% | 487,110 | 606.33M |
| 201 | VCYT | Veracyte, Inc. | 3.34B | 4.33% | 1,470,578 | 561.90M |
| 202 | RCUS | Arcus Biosciences, Inc. | 3.30B | 2.81% | 1,111,194 | 117.00M |
| 203 | DNLI | Denali Therapeutics Inc. | 3.27B | 3.80% | 2,393,794 | 3.60M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | 2.29% | 1,888,259 | 463.98M |
| 205 | DYN | Dyne Therapeutics, Inc. | 3.20B | 0.06% | 3,219,973 | - |
| 206 | QURE | uniQure N.V. | 3.07B | 0.70% | 801,233 | 18.67M |
| 207 | TMDX | TransMedics Group, Inc. | 3.03B | 1.01% | 591,039 | 668.47M |
| 208 | CLDX | Celldex Therapeutics, Inc. | 2.98B | -0.92% | 549,513 | 158.00K |
| 209 | NEOG | Neogen Corporation | 2.97B | 4.69% | 4,398,489 | 870.40M |
| 210 | ZLAB | Zai Lab Limited | 2.97B | 2.84% | 1,182,035 | 449.61M |
| 211 | ATRC | AtriCure, Inc. | 2.97B | 0.38% | 1,039,735 | 569.62M |
| 212 | MBX | MBX Biosciences, Inc. | 2.93B | -3.13% | 903,395 | - |
| 213 | RGC | Regencell Bioscience Holdings Limited | 2.93B | 2.25% | 113,557 | - |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.93B | -1.68% | 2,151,900 | 2.60B |
| 215 | WGS | GeneDx Holdings Corp. | 2.92B | -3.23% | 734,221 | 454.43M |
| 216 | WRBY | Warby Parker Inc. | 2.87B | 3.33% | 4,108,996 | 911.61M |
| 217 | IMNM | Immunome, Inc. | 2.85B | 4.59% | 1,180,593 | 4.02M |
| 218 | CDNA | CareDx, Inc. | 2.81B | 0.93% | 766,866 | 458.09M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.80B | -1.84% | 570,318 | 1.46B |
| 220 | PGEN | Precigen, Inc. | 2.76B | -1.03% | 3,240,276 | 85.72M |
| 221 | BKD | Brookdale Senior Living Inc. | 2.72B | -0.61% | 3,013,090 | 2.93B |
| 222 | NAMS | NewAmsterdam Pharma Company N.V. | 2.70B | 0.40% | 3,530,571 | 7.12M |
| 223 | AXGN | Axogen, Inc. | 2.69B | 3.84% | 1,199,842 | 251.17M |
| 224 | ACHC | Acadia Healthcare Company, Inc. | 2.64B | 0.14% | 1,492,987 | 3.37B |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.64B | -0.12% | 1,516,683 | 36.77M |
| 226 | IRON | Disc Medicine, Inc. | 2.63B | -1.50% | 406,550 | - |
| 227 | GPCR | Structure Therapeutics Inc. | 2.62B | 5.17% | 1,021,818 | - |
| 228 | PHVS | Pharvaris N.V. | 2.53B | -0.96% | 653,735 | - |
| 229 | BEAM | Beam Therapeutics Inc. | 2.52B | 1.24% | 1,703,948 | 156.04M |
| 230 | HCM | HUTCHMED (China) Limited | 2.52B | 5.93% | 114,331 | 549.12M |
| 231 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | 1.03% | 701,839 | - |
| 232 | PRVA | Privia Health Group, Inc. | 2.50B | -1.56% | 980,236 | 2.36B |
| 233 | NEO | NeoGenomics, Inc. | 2.49B | -2.51% | 1,435,170 | 766.30M |
| 234 | SUPN | Supernus Pharmaceuticals, Inc. | 2.49B | 1.86% | 635,722 | 830.44M |
| 235 | VERA | Vera Therapeutics, Inc. | 2.47B | 0.74% | 1,234,664 | - |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.45B | 0.19% | 839,024 | 959.90M |
| 237 | VRDN | Viridian Therapeutics, Inc. | 2.44B | -1.91% | 1,745,705 | 71.13M |
| 238 | ALMR | Alamar Biosciences, Inc. | 2.43B | 0.57% | 614,605 | 100.42M |
| 239 | CLOV | Clover Health Investments, Corp. | 2.41B | 1.79% | 2,843,092 | 2.48B |
| 240 | SLS | SELLAS Life Sciences Group, Inc. | 2.30B | -1.04% | 5,641,590 | - |
| 241 | NKTR | Nektar Therapeutics | 2.28B | -0.39% | 766,904 | 54.59M |
| 242 | SDGR | Schrödinger, Inc. | 2.26B | 4.20% | 2,888,571 | 259.04M |
| 243 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.24B | 0.92% | 3,462,947 | 940.61M |
| 244 | GENB | Generate Biomedicines, Inc. | 2.23B | 1.40% | 1,393,879 | 26.48M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.22B | 4.07% | 660,423 | 1.10B |
| 246 | TRLV | Trulieve Cannabis Corp. | 2.21B | 3.88% | 1,578,826 | 1.14B |
| 247 | PVLA | Palvella Therapeutics, Inc. | 2.21B | 1.89% | 123,592 | - |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | -1.72% | 668,286 | 311.51M |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.19B | - | 2,073,006 | 52.06M |
| 250 | INSP | Inspire Medical Systems, Inc. | 2.19B | -1.38% | 1,075,819 | 898.74M |
| 251 | UFPT | UFP Technologies, Inc. | 2.18B | 1.81% | 157,078 | 631.64M |
| 252 | BFLY | Butterfly Network, Inc. | 2.17B | 3.30% | 4,188,204 | 112.14M |
| 253 | BHVN | Biohaven Ltd. | 2.15B | 4.41% | 3,293,803 | - |
| 254 | NUVB | Nuvation Bio Inc. | 2.13B | 3.76% | 3,027,017 | 169.90M |
| 255 | RXRX | Recursion Pharmaceuticals, Inc. | 2.13B | 3.66% | 37,728,730 | 54.86M |
| 256 | ADMA | ADMA Biologics, Inc. | 2.13B | 4.34% | 2,859,100 | 512.28M |
| 257 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | 0.15% | 1,756,604 | 1.97B |
| 258 | ZBIO | Zenas BioPharma, Inc. | 2.12B | 3.33% | 414,502 | 1.00M |
| 259 | TRVI | Trevi Therapeutics, Inc. | 2.12B | -0.40% | 1,649,387 | - |
| 260 | URGN | UroGen Pharma Ltd. | 2.11B | -0.12% | 482,488 | 188.73M |
| 261 | ADUS | Addus HomeCare Corporation | 2.11B | -1.46% | 158,296 | 1.48B |
| 262 | BHC | Bausch Health Companies Inc. | 2.11B | -0.53% | 1,539,564 | 10.85B |
| 263 | ALVO | Alvotech | 2.10B | 0.17% | 1,313,024 | 494.61M |
| 264 | CMPS | COMPASS Pathways plc | 2.08B | -1.18% | 3,449,430 | - |
| 265 | PGNY | Progyny, Inc. | 2.06B | -1.00% | 821,052 | 1.31B |
| 266 | MD | Pediatrix Medical Group, Inc. | 2.04B | -0.62% | 506,763 | 1.95B |
| 267 | KOD | Kodiak Sciences Inc. | 2.03B | -0.89% | 666,415 | - |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | 2.66% | 884,551 | 98.34M |
| 269 | VCEL | Vericel Corporation | 2.03B | -1.17% | 402,176 | 306.30M |
| 270 | ESTA | Establishment Labs Holdings Inc. | 2.02B | -2.25% | 258,891 | 245.82M |
| 271 | MESO | Mesoblast Limited | 2.00B | 2.31% | 165,745 | 120.25M |
| 272 | PRGO | Perrigo Company plc | 1.96B | 4.20% | 1,709,346 | 4.14B |
| 273 | NVCR | NovoCure Limited | 1.92B | -0.96% | 633,461 | 699.19M |
| 274 | GHRS | GH Research PLC | 1.92B | -1.17% | 131,168 | - |
| 275 | LKFT | Lakefront Biotherapeutics NV | 1.91B | 3.64% | 208,124 | 1.13B |
| 276 | FTRE | Fortrea Holdings Inc. | 1.90B | 0.45% | 1,051,230 | 2.68B |
| 277 | RAPP | Rapport Therapeutics, Inc. | 1.90B | -1.95% | 616,978 | 20.00M |
| 278 | ZYME | Zymeworks Inc. | 1.90B | 0.90% | 582,618 | 37.13M |
| 279 | XRAY | DENTSPLY SIRONA Inc. | 1.88B | -1.05% | 6,647,164 | 3.64B |
| 280 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.86B | 2.87% | 2,300,323 | 208.78M |
| 281 | XNCR | Xencor, Inc. | 1.86B | 1.25% | 1,389,707 | 104.97M |
| 282 | VIR | Vir Biotechnology, Inc. | 1.84B | 2.64% | 1,454,929 | 303.23M |
| 283 | BLFS | BioLife Solutions, Inc. | 1.82B | 1.34% | 406,601 | 106.69M |
| 284 | LMAT | LeMaitre Vascular, Inc. | 1.81B | 0.42% | 221,532 | 262.43M |
| 285 | STOK | Stoke Therapeutics, Inc. | 1.81B | -1.34% | 720,047 | 27.59M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.81B | -0.39% | 289,884 | 481.07M |
| 287 | SEPN | Septerna, Inc. | 1.80B | -0.39% | 252,437 | 98.88M |
| 288 | FRNM | Freenome, Inc. | 1.78B | -2.98% | 588,228 | 35.41M |
| 289 | COAG | Hemab Therapeutics Holdings, Inc. | 1.77B | -7.82% | 556,767 | - |
| 290 | SGRY | Surgery Partners, Inc. | 1.77B | 3.09% | 2,311,456 | 3.37B |
| 291 | TYRA | Tyra Biosciences, Inc. | 1.76B | -0.31% | 989,218 | - |
| 292 | PSNL | Personalis, Inc. | 1.73B | -0.98% | 1,816,252 | 69.67M |
| 293 | NBTX | Nanobiotix S.A. | 1.73B | 4.39% | 94,529 | 38.27M |
| 294 | ALHC | Alignment Healthcare, Inc. | 1.73B | -0.24% | 13,586,241 | 4.58B |
| 295 | NVAX | Novavax, Inc. | 1.72B | 2.97% | 6,135,453 | 413.80M |
| 296 | ASTH | Astrana Health, Inc. | 1.72B | -2.36% | 603,496 | 3.84B |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.71B | 0.66% | 3,738,743 | 59.51M |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.69B | 3.56% | 579,335 | 978.38M |
| 299 | ABSI | Absci Corporation | 1.69B | 1.76% | 4,559,441 | 1.56M |
| 300 | IMCR | Immunocore Holdings plc | 1.66B | 0.56% | 265,976 | 430.78M |
| 301 | INBX | Inhibrx Biosciences, Inc. | 1.65B | 2.46% | 249,134 | 1.30M |
| 302 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | 0.40% | 1,676,219 | 5.49M |
| 303 | ANAB | AnaptysBio, Inc. | 1.63B | -0.51% | 525,048 | 232.39M |
| 304 | SNDX | Syndax Pharmaceuticals, Inc. | 1.61B | 2.55% | 2,108,266 | 252.25M |
| 305 | BRVE | Braveheart Bio, Inc. | 1.61B | -14.32% | 1,571,357 | - |
| 306 | XERS | Xeris Biopharma Holdings, Inc. | 1.60B | 7.32% | 3,231,385 | 335.41M |
| 307 | ETON | Eton Pharmaceuticals, Inc. | 1.58B | -0.34% | 335,508 | 105.60M |
| 308 | ATEC | Alphatec Holdings, Inc. | 1.57B | -0.10% | 1,699,936 | 815.05M |
| 309 | KLRA | Kailera Therapeutics, Inc. | 1.55B | -6.55% | 1,050,489 | - |
| 310 | KARD | Kardigan, Inc. | 1.52B | -2.04% | 724,482 | - |
| 311 | INVA | Innoviva, Inc. | 1.52B | -0.47% | 688,522 | 440.00M |
| 312 | KRSA | Korsana Biosciences, Inc. | 1.51B | -5.09% | 21,681 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.50B | 1.24% | 456,772 | 6.41B |
| 314 | AAPG | Ascentage Pharma Group International | 1.49B | 5.31% | 17,354 | 94.61M |
| 315 | OMCL | Omnicell, Inc. | 1.48B | 0.62% | 434,860 | 1.25B |
| 316 | AZTA | Azenta, Inc. | 1.48B | 1.53% | 718,185 | 613.81M |
| 317 | AGL | agilon health, inc. | 1.48B | -1.27% | 290,948 | 5.92B |
| 318 | KMTS | Kestra Medical Technologies, Ltd. | 1.48B | 1.39% | 144,131 | 106.73M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.47B | 2.91% | 936,996 | - |
| 320 | HCSG | Healthcare Services Group, Inc. | 1.46B | -0.79% | 736,085 | 1.86B |
| 321 | BCAX | Bicara Therapeutics Inc. | 1.46B | -2.78% | 315,355 | - |
| 322 | INNV | InnovAge Holding Corp. | 1.45B | -2.93% | 240,190 | 989.71M |
| 323 | RARE | Ultragenyx Pharmaceutical Inc. | 1.44B | 0.96% | 5,270,376 | 717.00M |
| 324 | DRTS | Alpha Tau Medical Ltd. | 1.43B | 1.71% | 412,752 | - |
| 325 | DMRA | Damora Therapeutics, Inc. | 1.41B | 1.15% | 618,453 | - |
| 326 | PAHC | Phibro Animal Health Corporation | 1.41B | 0.35% | 141,339 | 1.52B |
| 327 | AVLN | Avalyn Pharma Inc. | 1.40B | 0.32% | 177,307 | - |
| 328 | LTGO | Latigo Biotherapeutics, Inc. | 1.40B | -6.39% | 411,908 | - |
| 329 | TRAX | First Tracks Biotherapeutics, Inc. | 1.39B | 1.01% | 661,252 | - |
| 330 | LBRX | LB Pharmaceuticals Inc | 1.39B | 1.22% | 310,155 | - |
| 331 | SVRA | Savara Inc. | 1.39B | 1.49% | 1,311,924 | - |
| 332 | NUTX | Nutex Health Inc. | 1.38B | -3.50% | 115,517 | 846.72M |
| 333 | CGEM | Cullinan Therapeutics, Inc. | 1.37B | 1.28% | 763,872 | - |
| 334 | PNTG | The Pennant Group, Inc. | 1.36B | -1.67% | 272,260 | 1.10B |
| 335 | CNMD | CONMED Corporation | 1.34B | -1.61% | 354,663 | 1.37B |
| 336 | OMER | Omeros Corporation | 1.34B | 3.47% | 1,055,633 | 38.42M |
| 337 | AMN | AMN Healthcare Services, Inc. | 1.33B | -0.06% | 374,819 | 3.43B |
| 338 | ORIC | ORIC Pharmaceuticals, Inc. | 1.31B | -0.94% | 835,962 | - |
| 339 | CERT | Certara, Inc. | 1.30B | 1.19% | 1,896,851 | 421.75M |
| 340 | VOR | Vor Biopharma Inc. | 1.30B | 2.29% | 1,864,109 | - |
| 341 | HROW | Harrow, Inc. | 1.27B | 2.54% | 611,428 | 275.59M |
| 342 | OMDA | Omada Health, Inc. | 1.26B | 0.88% | 791,554 | 309.76M |
| 343 | OPK | OPKO Health, Inc. | 1.26B | 1.20% | 1,781,178 | 587.90M |
| 344 | MGTX | MeiraGTx Holdings plc | 1.26B | -1.28% | 1,286,206 | 397.50M |
| 345 | MAZE | Maze Therapeutics, Inc. | 1.24B | -0.58% | 516,972 | 20.00M |
| 346 | USPH | U.S. Physical Therapy, Inc. | 1.23B | -0.02% | 169,776 | 804.27M |
| 347 | TNDM | Tandem Diabetes Care, Inc. | 1.23B | 4.45% | 2,101,592 | 1.04B |
| 348 | CRON | Cronos Group Inc. | 1.22B | -0.60% | 472,128 | 179.09M |
| 349 | REPL | Replimune Group, Inc. | 1.21B | -1.53% | 1,461,786 | - |
| 350 | IART | Integra LifeSciences Holdings Corporation | 1.21B | 2.43% | 1,064,158 | 1.65B |
| 351 | ANRO | Alto Neuroscience, Inc. | 1.20B | 1.19% | 357,799 | - |
| 352 | IMTX | Immatics N.V. | 1.19B | 1.16% | 305,398 | 47.65M |
| 353 | AKTS | Aktis Oncology, Inc. | 1.19B | -2.06% | 614,263 | 10.06M |
| 354 | BBNX | Beta Bionics, Inc. | 1.16B | 0.69% | 783,296 | 119.01M |
| 355 | GDRX | GoodRx Holdings, Inc. | 1.16B | 0.30% | 557,186 | 785.23M |
| 356 | AORT | Artivion, Inc. | 1.15B | 1.20% | 569,146 | 471.47M |
| 357 | TDOC | Teladoc Health, Inc. | 1.14B | -0.48% | 2,996,186 | 2.49B |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.13B | -1.26% | 234,266 | - |
| 359 | MNKD | MannKind Corporation | 1.13B | -1.13% | 4,527,406 | 393.63M |
| 360 | BVS | Bioventus Inc. | 1.12B | 3.10% | 473,430 | 581.85M |
| 361 | ODTX | Odyssey Therapeutics, Inc. | 1.10B | -5.41% | 245,658 | 99.00K |
| 362 | APMD | Apnimed, Inc. | 1.09B | -9.59% | 1,511,254 | 115.12M |
| 363 | OBX | Obsidian Therapeutics, Inc. | 1.07B | -2.37% | 1,104,890 | - |
| 364 | CSTL | Castle Biosciences, Inc. | 1.07B | -0.99% | 391,677 | 357.28M |
| 365 | MLTX | MoonLake Immunotherapeutics | 1.07B | 1.29% | 1,220,132 | - |
| 366 | JBIO | Jade Biosciences, Inc. | 1.06B | -1.18% | 528,776 | - |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.06B | -4.09% | 1,114,642 | 337.34M |
| 368 | IRMD | IRADIMED CORPORATION | 1.05B | 0.41% | 120,118 | 86.34M |
| 369 | GLUE | Monte Rosa Therapeutics, Inc. | 1.05B | 1.07% | 1,128,251 | 28.73M |
| 370 | CRVS | Corvus Pharmaceuticals, Inc. | 1.04B | -1.11% | 939,789 | - |
| 371 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.04B | 3.64% | 595,754 | 730.02M |
| 372 | ENOV | Enovis Corporation | 1.04B | - | 2,593,889 | 2.30B |
| 373 | JANX | Janux Therapeutics, Inc. | 1.04B | 2.53% | 701,841 | 24.00M |
| 374 | KURA | Kura Oncology, Inc. | 1.03B | -1.11% | 1,763,389 | 77.23M |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | -3.61% | 455,280 | 1.04B |
| 376 | ALMS | Alumis Inc. | 1.02B | 1.67% | 2,433,339 | 7.40M |
| 377 | STAA | STAAR Surgical Company | 1.02B | -2.40% | 768,555 | 339.59M |
| 378 | ANL | Adlai Nortye Group Ltd. | 1.00B | -1.08% | 92,591 | 18.06M |
| 379 | HELP | Cybin Inc. | 998.00M | 10.43% | 2,873,445 | - |
| 380 | ABUS | Arbutus Biopharma Corporation | 989.24M | -0.20% | 4,562,773 | 181.72M |
| 381 | SLBT | SL Science Holding Limited | 980.86M | - | 56,707 | 3.27M |
| 382 | ATTO | Attovia Therapeutics, Inc. | 972.37M | -3.79% | 460,932 | 1.80M |
| 383 | PCRX | Pacira BioSciences, Inc. | 961.07M | -2.35% | 375,530 | 746.16M |
| 384 | SGP | SpyGlass Pharma, Inc. | 935.21M | -3.85% | 174,297 | - |
| 385 | CBLL | CeriBell, Inc. | 930.67M | -0.49% | 309,465 | 101.96M |
| 386 | SANA | Sana Biotechnology, Inc. | 928.02M | - | 2,005,011 | - |
| 387 | SLDB | Solid Biosciences Inc. | 915.70M | -4.15% | 1,170,810 | - |
| 388 | LXRX | Lexicon Pharmaceuticals, Inc. | 907.71M | -0.49% | 2,506,461 | 41.47M |
| 389 | GMRS | GMR Solutions Inc. | 897.69M | -7.82% | 1,099,070 | 5.88B |
| 390 | IMMX | Immix Biopharma, Inc. | 892.10M | -0.24% | 1,329,529 | - |
| 391 | HSTM | HealthStream, Inc. | 889.73M | -0.51% | 176,353 | 321.12M |
| 392 | TBPH | Theravance Biopharma, Inc. | 885.21M | 0.18% | 667,296 | 104.31M |
| 393 | RIGL | Rigel Pharmaceuticals, Inc. | 879.63M | 0.96% | 164,839 | 276.79M |
| 394 | ETRA | Electra Therapeutics, Inc. | 873.72M | 5.06% | 813,177 | - |
| 395 | ARDX | Ardelyx, Inc. | 872.16M | 2.34% | 2,834,103 | 450.89M |
| 396 | AVTX | Avalo Therapeutics, Inc. | 867.20M | -2.41% | 542,683 | 59.00K |
| 397 | FTH | Faeth Therapeutics, Inc. | 860.23M | -3.51% | 379,204 | - |
| 398 | CADL | Candel Therapeutics, Inc. | 857.77M | 3.32% | 1,086,919 | - |
| 399 | IVA | Inventiva S.A. | 850.92M | -3.44% | 1,369,125 | 7.94M |
| 400 | OLMA | Olema Pharmaceuticals, Inc. | 842.60M | -1.93% | 1,070,361 | - |
| 401 | FDMT | 4D Molecular Therapeutics, Inc. | 841.92M | 0.13% | 699,178 | 92.01M |
| 402 | WVE | Wave Life Sciences, Inc. | 838.44M | -2.18% | 2,372,996 | 65.37M |
| 403 | GERN | Geron Corporation | 835.22M | - | 5,897,022 | 204.56M |
| 404 | INMD | InMode Ltd. | 833.47M | 1.05% | 336,473 | 374.63M |
| 405 | ACHV | Achieve Life Sciences, Inc. | 828.37M | 0.88% | 1,006,915 | - |
| 406 | SIBN | SI-BONE, Inc. | 826.90M | 1.99% | 771,146 | 213.60M |
| 407 | BLSM | BlossomHill Therapeutics, Inc. | 821.25M | 4.12% | 292,222 | - |
| 408 | ACRS | Aclaris Therapeutics, Inc. | 819.90M | 1.27% | 1,521,431 | 8.22M |
| 409 | ANNX | Annexon, Inc. | 800.02M | -0.24% | 4,187,459 | - |
| 410 | AVR | Anteris Technologies Global Corp. | 794.29M | -0.12% | 744,257 | 2.24M |
| 411 | GYRE | Gyre Therapeutics, Inc. | 787.83M | -1.59% | 364,870 | 109.82M |
| 412 | DSGN | Design Therapeutics, Inc. | 785.40M | 2.53% | 506,443 | - |
| 413 | CLYM | Climb Bio, Inc. | 783.43M | -2.92% | 1,222,283 | - |
| 414 | VREX | Varex Imaging Corporation | 778.47M | -0.11% | 323,538 | 865.00M |
| 415 | AHCO | AdaptHealth Corp. | 767.10M | 0.70% | 2,779,907 | 3.36B |
| 416 | PHAR | Pharming Group N.V. | 753.32M | 2.46% | 218,384 | 366.48M |
| 417 | COLL | Collegium Pharmaceutical, Inc. | 750.08M | 1.19% | 928,274 | 808.21M |
| 418 | GLAS | Glass House Brands Inc. | 748.29M | -0.38% | 683,893 | 176.98M |
| 419 | QDEL | QuidelOrtho Corporation | 744.73M | 2.26% | 1,069,562 | 2.67B |
| 420 | SLN | Silence Therapeutics plc | 737.56M | 0.41% | 665,750 | 615.00K |
| 421 | IRWD | Ironwood Pharmaceuticals, Inc. | 728.71M | 1.15% | 2,414,989 | 389.32M |
| 422 | VSTM | Verastem, Inc. | 723.60M | 7.39% | 2,800,862 | 87.53M |
| 423 | DBVT | DBV Technologies S.A. | 723.58M | -2.02% | 131,426 | 5.04M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 716.14M | -0.09% | 166,374 | - |
| 425 | SOPH | SOPHiA GENETICS SA | 701.45M | 0.61% | 430,114 | 86.17M |
| 426 | MDXG | MiMedx Group, Inc. | 701.11M | 0.84% | 915,909 | 355.17M |
| 427 | STLN | Starling Oncology, Inc. | 696.09M | -1.87% | 1,253,248 | 587.24M |
| 428 | CBIO | Crescent Biopharma, Inc. | 695.52M | -3.79% | 375,775 | 11.88M |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 693.01M | 0.52% | 714,955 | 136.07M |
| 430 | CTKB | Cytek Biosciences, Inc. | 686.31M | -0.38% | 1,254,765 | 206.71M |
| 431 | SGMT | Sagimet Biosciences Inc. | 671.31M | -2.61% | 753,263 | - |
| 432 | OABI | OmniAb, Inc. | 665.89M | 2.46% | 1,364,402 | 38.46M |
| 433 | AURA | Aura Biosciences, Inc. | 659.56M | -1.24% | 819,097 | - |
| 434 | SSII | SS Innovations International, Inc. | 659.27M | 0.92% | 77,581 | 52.40M |
| 435 | NGNE | Neurogene Inc. | 651.77M | 1.50% | 325,534 | 925.00K |
| 436 | AHG | Akso Health Group | 651.10M | 1.16% | 4,165 | 13.83M |
| 437 | MNPR | Monopar Therapeutics Inc. | 642.49M | -0.78% | 89,237 | - |
| 438 | ANGO | AngioDynamics, Inc. | 637.35M | -0.13% | 315,683 | 320.17M |
| 439 | ALT | Altimmune, Inc. | 636.07M | 0.62% | 3,523,050 | 31.00K |
| 440 | OCS | Oculis Holding AG | 625.96M | - | 201,825 | 1.45M |
| 441 | PHR | Phreesia, Inc. | 622.57M | -0.10% | 790,156 | 507.79M |
| 442 | VALN | Valneva SE | 620.56M | 0.91% | 18,939 | 163.30M |
| 443 | STTK | Shattuck Labs, Inc. | 613.22M | 1.66% | 1,037,075 | 1.00M |
| 444 | MPLT | MapLight Therapeutics, Inc. | 605.78M | -0.18% | 542,938 | - |
| 445 | CRMD | CorMedix Inc. | 605.63M | 0.65% | 505,842 | 462.25M |
| 446 | CTMX | CytomX Therapeutics, Inc. | 601.40M | - | 2,331,036 | 18.30M |
| 447 | AQST | Aquestive Therapeutics, Inc. | 599.95M | 3.69% | 2,455,976 | 54.09M |
| 448 | DRUG | Bright Minds Biosciences Inc. | 593.40M | -2.49% | 91,656 | - |
| 449 | FLGT | Fulgent Genetics, Inc. | 592.68M | -0.69% | 348,832 | 323.93M |
| 450 | PHAT | Phathom Pharmaceuticals, Inc. | 591.75M | -0.40% | 898,883 | 239.66M |
| 451 | WEAV | Weave Communications, Inc. | 585.59M | 0.41% | 1,267,684 | 257.79M |
| 452 | ALLO | Allogene Therapeutics, Inc. | 583.88M | - | 5,992,402 | 4.64M |
| 453 | KIDS | OrthoPediatrics Corp. | 583.55M | 2.43% | 208,083 | 252.72M |
| 454 | AGMB | AgomAb Therapeutics NV | 576.20M | -3.86% | 85,405 | - |
| 455 | EVO | Evotec SE | 569.60M | -3.75% | 685,697 | 819.47M |
| 456 | EPRX | Eupraxia Pharmaceuticals Inc. | 568.75M | 0.70% | 314,187 | - |
| 457 | PRME | Prime Medicine, Inc. | 567.51M | 2.24% | 2,946,304 | 4.07M |
| 458 | DCTH | Delcath Systems, Inc. | 559.00M | - | 365,511 | 95.42M |
| 459 | TLRY | Tilray Brands, Inc. | 558.93M | 2.26% | 3,665,463 | 915.45M |
| 460 | BWAY | BrainsWay Ltd. | 543.39M | -0.29% | 59,645 | 60.70M |
| 461 | ARVN | Arvinas, Inc. | 542.71M | 0.12% | 639,844 | 316.70M |
| 462 | DNA | Ginkgo Bioworks Holdings, Inc. | 537.38M | 1.27% | 1,653,358 | 132.42M |
| 463 | PROK | ProKidney Corp. | 536.62M | -7.07% | 1,772,953 | 818.00K |
| 464 | CTEV | Claritev Corporation | 535.88M | 2.63% | 184,648 | 994.67M |
| 465 | SCTX | Scribe Therapeutics Inc. | 531.03M | -15.00% | 528,814 | 33.30M |
| 466 | OVID | Ovid Therapeutics Inc. | 529.26M | 0.74% | 1,183,520 | 1.58M |
| 467 | EOLS | Evolus, Inc. | 527.74M | 1.65% | 420,740 | 316.49M |
| 468 | TECX | Tectonic Therapeutic, Inc. | 520.60M | -1.37% | 131,808 | - |
| 469 | RGNX | REGENXBIO Inc. | 520.18M | -1.87% | 1,115,691 | 174.48M |
| 470 | ASMB | Assembly Biosciences, Inc. | 517.97M | 1.88% | 211,868 | 74.85M |
| 471 | TCMD | Tactile Systems Technology, Inc. | 517.60M | 2.93% | 201,530 | 350.31M |
| 472 | CAPR | Capricor Therapeutics, Inc. | 517.44M | -1.77% | 2,419,019 | 11.13M |
| 473 | SENS | Senseonics Holdings, Inc. | 517.11M | 2.09% | 897,497 | 48.55M |
| 474 | AUTL | Autolus Therapeutics plc | 516.36M | - | 1,101,473 | 117.39M |
| 475 | CERS | Cerus Corporation | 515.90M | -3.40% | 1,915,017 | 221.55M |
| 476 | ENTX | Entera Bio Ltd. | 512.50M | - | 294,685 | 42.00K |
| 477 | CTNM | Contineum Therapeutics, Inc. | 509.77M | 0.15% | 638,481 | - |
| 478 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 479 | KMDA | Kamada Ltd. | 501.36M | -1.24% | 115,461 | 191.85M |
| 480 | NPCE | NeuroPace, Inc. | 499.07M | 1.82% | 71,732 | 106.99M |
| 481 | PBYI | Puma Biotechnology, Inc. | 495.04M | -0.10% | 217,570 | 231.24M |
| 482 | PRLD | Prelude Therapeutics Incorporated | 484.08M | -3.49% | 392,657 | 22.42M |
| 483 | EIKN | Eikon Therapeutics, Inc. | 478.28M | -1.34% | 463,893 | - |
| 484 | SRTA | Strata Critical Medical, Inc. | 477.72M | 1.12% | 573,610 | 255.98M |
| 485 | NRC | NRC Health | 470.48M | 3.45% | 158,548 | 140.00M |
| 486 | SGHT | Sight Sciences, Inc. | 467.70M | 5.86% | 223,555 | 83.38M |
| 487 | TTRX | Turn Therapeutics Inc. | 456.95M | 2.68% | 172,958 | - |
| 488 | MASS | 908 Devices Inc. | 449.71M | 3.32% | 343,698 | 60.84M |
| 489 | TKNO | Alpha Teknova, Inc. | 447.76M | 7.06% | 438,359 | 43.70M |
| 490 | RLMD | Relmada Therapeutics, Inc. | 443.75M | 0.97% | 552,734 | - |
| 491 | KYTX | Kyverna Therapeutics, Inc. | 440.33M | -0.14% | 678,463 | - |
| 492 | VOGX | Vogenx, Inc. | 438.23M | -9.23% | 245,849 | - |
| 493 | PRTA | Prothena Corporation plc | 436.88M | -0.82% | 363,158 | 54.53M |
| 494 | AVIR | Atea Pharmaceuticals, Inc. | 435.51M | 1.88% | 440,096 | - |
| 495 | EDIT | Editas Medicine, Inc. | 434.63M | 4.81% | 2,490,535 | 47.01M |
| 496 | IRD | Opus Genetics, Inc. | 434.28M | 0.77% | 1,980,811 | 9.86M |
| 497 | SPRY | ARS Pharmaceuticals, Inc. | 432.60M | 5.84% | 1,197,966 | 116.93M |
| 498 | ZURA | Zura Bio Limited | 431.23M | 0.90% | 1,111,085 | - |
| 499 | CLPT | ClearPoint Neuro, Inc. | 426.14M | 1.01% | 373,357 | 42.28M |
| 500 | CARL | Carlsmed, Inc. | 425.92M | 0.13% | 58,980 | 63.30M |